Label-Free Detection of G Protein–SNARE Interactions and Screening for Small Molecule Modulators

Authors:

Abstract
Gi/o-coupled presynaptic GPCRs are major targets in neuropsychiatric diseases. For example, presynaptic auto- or heteroreceptors include the D2 dopamine receptor, H3 histamine receptor, 5HT1 serotonin receptors, M4 acetylcholine receptors, GABAB receptors, Class II and III metabotropic glutamate receptors, opioid receptors, as well as many other receptors. These GPCRs exert their influence by decreasing exocytosis of synaptic vesicles. One mechanism by which they act is through direct interaction of the Gβγ subunit with members of the SNARE complex downstream of voltage-dependent calcium channels, and specifically with the C-terminus of SNAP25 and the H3 domain of syntaxin1A. (Gerachshenko, T., Blackmer, T., Yoon, E. J., Bartleson, C., Hamm, H. E., and Alford, S. (2005) Gβγ acts at the C terminus of SNAP-25 to mediate presynaptic inhibition, Nat. Neurosci.8, 597–605; Yoon, E. J., Gerachshenko, T., Spiegelberg, B. D., Alford, S., and Hamm, H. E. (2007) Gβγ interferes with Ca2+-dependent binding of synaptotagmin to the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex, Mol. Pharmacol.72, 1210–1219; Blackmer, T., Larsen, E. C., Bartleson, C., Kowalchyk, J. A., Yoon, E. J., Preininger, A. M., Alford, S., Hamm, H. E., and Martin, T. F. (2005) G protein βγ directly regulates SNARE protein fusion machinery for secretory granule exocytosis, Nat. Neurosci.8, 421–425).(1-3) Small molecule inhibitors of the Gβγ–SNARE interaction would allow the study of the relative importance of this mechanism in more detail. We have utilized novel, label-free technology to detect this protein–protein interaction and screen for several small molecule compounds that perturb the interaction, demonstrating the viability of this approach. Interestingly, the screen also produced enhancers of the Gβγ–SNARE interaction.

This publication has 34 references indexed in Scilit: